Karim NA, Miao J, Reckamp KL, Gay CM, et al. Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929. J Thorac Oncol 2024 Nov 4:S1556-0864(24)02431.
PMID: 39505259